Johnson & Johnson (JNJ) News Today → “Dollar Will Be Worth NOTHING” -Musk (From Crypto 101 Media) (Ad) Free JNJ Stock Alerts $154.27 +1.60 (+1.05%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 10:22 PM | marketbeat.comShort Interest in Johnson & Johnson (NYSE:JNJ) Expands By 6.7%Johnson & Johnson (NYSE:JNJ - Get Free Report) was the recipient of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 17,670,000 shares, an increase of 6.7% from the April 15th total of 16,560,000 shares. Approximately 0.7% of the shares of the company are sold short. Based on an average daily trading volume, of 7,630,000 shares, the days-to-cover ratio is presently 2.3 days.May 16 at 5:01 PM | msn.comRare but deadly blood clots tied to Johnson & Johnson and AstraZeneca Covid-19 vaccines: scientists report to journalMay 16 at 5:01 PM | markets.businessinsider.comJohnson & Johnson To Acquire Proteologix For $850 MlnMay 16 at 5:01 PM | finance.yahoo.comJohnson & Johnson to Buy Proteologix For $850 Million in CashMay 16 at 5:01 PM | finance.yahoo.comJohnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850MMay 16 at 4:42 PM | marketbeat.comJohnson & Johnson (NYSE:JNJ) Shares Up 0.3%Johnson & Johnson (NYSE:JNJ) Shares Up 0.3%May 16 at 1:27 PM | marketbeat.comJohnson & Johnson (NYSE:JNJ) Rating Reiterated by Royal Bank of CanadaRoyal Bank of Canada reissued an "outperform" rating and issued a $175.00 price objective on shares of Johnson & Johnson in a research note on Thursday.May 16 at 10:46 AM | marketbeat.comHikari Tsushin Inc. Reduces Holdings in Johnson & Johnson (NYSE:JNJ)Hikari Tsushin Inc. cut its position in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 4.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 136,468 shares of the company's stoMay 16 at 8:01 AM | finance.yahoo.comJohnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis TreatmentMay 16 at 7:40 AM | reuters.comJohnson & Johnson to acquire Proteologix for $850 millionMay 15 at 7:41 PM | marketbeat.comJohnson & Johnson (NYSE:JNJ) Shares Up 0.1%Johnson & Johnson (NYSE:JNJ) Shares Up 0.1%May 15 at 4:06 PM | seekingalpha.comJohnson & Johnson (JNJ) RBC Capital Markets Global Healthcare Conference (Transcript)May 15 at 9:33 AM | marketbeat.comIeq Capital LLC Cuts Position in Johnson & Johnson (NYSE:JNJ)Ieq Capital LLC decreased its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 24.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 107,201 shares of the company's stock after selling 34,529 shares during the periMay 14 at 8:13 PM | seekingalpha.comJohnson & Johnson (JNJ) BofA Securities Health Care Conference (Transcript)May 14 at 8:13 PM | seekingalpha.comJohnson & Johnson (JNJ) Management Presents at BofA Securities Health Care Conference (Transcript)May 14 at 6:56 PM | finance.yahoo.comIs Ardagh Metal Packaging SA (NYSE:AMBP) the Best High-Dividend Penny Stock to Buy Now?May 14 at 2:53 PM | marketbeat.comJohnson & Johnson (NYSE:JNJ) Shares Up 0.2%Johnson & Johnson (NYSE:JNJ) Stock Price Up 0.2%May 14 at 7:41 AM | marketbeat.comSeizert Capital Partners LLC Lowers Position in Johnson & Johnson (NYSE:JNJ)Seizert Capital Partners LLC lessened its position in Johnson & Johnson (NYSE:JNJ - Free Report) by 4.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 250,330 shares of the company's stock after selling 11,632May 13, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Stock Price Up 0.6%Johnson & Johnson (NYSE:JNJ) Trading Up 0.6%May 13, 2024 | benzinga.comJohnson & Johnson's Subsidiary Discontinues Some Megadyne Electrodes For Pediatric UseMay 13, 2024 | finance.yahoo.comWe Think Johnson & Johnson (NYSE:JNJ) Can Stay On Top Of Its DebtMay 13, 2024 | finance.yahoo.comSector Update: Consumer Stocks Gain Premarket MondayMay 13, 2024 | finance.yahoo.comJohnson & Johnson to sell remaining stake in KenvueMay 13, 2024 | investorplace.comJohnson & Johnson Is Officially Getting Out of Kenvue (KVUE) StockMay 13, 2024 | marketbeat.comNorthwest Financial Advisors Makes New Investment in Johnson & Johnson (NYSE:JNJ)Northwest Financial Advisors bought a new stake in shares of Johnson & Johnson (NYSE:JNJ - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 10,505 shares of the company's stock, valued at approximMay 13, 2024 | fool.com2 Supercharged Dividend Stocks to Buy and Hold for YearsMay 13, 2024 | businesswire.comKenvue Announces Launch of Secondary OfferingMay 13, 2024 | investorplace.com7 Reliable Dividend Stocks to Keep Your Portfolio UprightMay 13, 2024 | investorplace.comThe 7 Most Undervalued Stocks With Strong Fundamentals to Buy in May 2024May 12, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Shares Sold by Troy Asset Management LtdTroy Asset Management Ltd reduced its position in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 5.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 283,503 shares of the company's stock aMay 12, 2024 | americanbankingnews.comJohnson & Johnson (NYSE:JNJ) Trading Down 0.3%May 11, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Stake Increased by National Pension ServiceNational Pension Service grew its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 2.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,853,788 shares of the company's stock after purchasing an additional 76,8May 11, 2024 | americanbankingnews.comEquities Analysts Offer Predictions for Johnson & Johnson's Q3 2024 Earnings (NYSE:JNJ)May 10, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Stock Price Down 0.3%Johnson & Johnson (NYSE:JNJ) Shares Down 0.3%May 10, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Shares Sold by Welch & Forbes LLCWelch & Forbes LLC decreased its position in Johnson & Johnson (NYSE:JNJ - Free Report) by 1.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 768,845 shares of the company's stock after selling 14,706 shares during the period. JoMay 10, 2024 | marketbeat.comQ3 2024 EPS Estimates for Johnson & Johnson (NYSE:JNJ) Cut by AnalystJohnson & Johnson (NYSE:JNJ - Free Report) - Investment analysts at Zacks Research lowered their Q3 2024 earnings estimates for shares of Johnson & Johnson in a research note issued on Tuesday, May 7th. Zacks Research analyst K. Shah now forecasts that the company will earn $2.70 per share for thMay 10, 2024 | fool.comPrediction: 3 Sensational Stocks That'll Be Worth Far More Than Tesla 2 Years From NowMay 10, 2024 | americanbankingnews.comQ2 2024 EPS Estimates for Johnson & Johnson (NYSE:JNJ) Lifted by AnalystMay 9, 2024 | markets.businessinsider.comHold Rating on Johnson & Johnson Amid Varipulse PFA Catheter Recall and Approval UncertaintiesMay 9, 2024 | finance.yahoo.comJohnson & Johnson (NYSE:JNJ) Is Increasing Its Dividend To $1.24May 9, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Trading Up 0.7%Johnson & Johnson (NYSE:JNJ) Trading Up 0.7%May 9, 2024 | businesswire.comSHOCKWAVE MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Shockwave Medical, Inc. - SWAVMay 9, 2024 | finance.yahoo.com3 Reliable Dividend Stocks For Long-Term Passive IncomeMay 9, 2024 | marketbeat.comRiver Global Investors LLP Purchases 33,629 Shares of Johnson & Johnson (NYSE:JNJ)River Global Investors LLP boosted its position in Johnson & Johnson (NYSE:JNJ - Free Report) by 691.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 38,492 shares of the company's stock after purchasing an additional 33,629 sharMay 9, 2024 | americanbankingnews.comQ2 2024 EPS Estimates for Johnson & Johnson (NYSE:JNJ) Increased by AnalystMay 9, 2024 | fool.comWhat Is the Dividend Payout for Johnson & Johnson Stock?May 8, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Trading Up 0.1%Johnson & Johnson (NYSE:JNJ) Stock Price Up 0.1%May 8, 2024 | tmcnet.comJohnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceMay 8, 2024 | investorplace.comThe 3 Most Undervalued S&P 500 Stocks to Buy in May 2024May 8, 2024 | investorplace.comSteady Dividend Plays: 3 Stocks Promising Reliable Payouts in 2024 Get Johnson & Johnson News Delivered to You Automatically Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter. Email Address “Dollar Will Be Worth NOTHING” -Musk (Ad)Elon Musk just issued an urgent warning… Saying “The U.S. Dollar will be worth NOTHING…” As "stealth money printing" pushes the price of Bitcoin, Ethereum, XRP and crypto higher. Click here to claim your free seat ticket now. JNJ Media Mentions By Week JNJ Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JNJ News Sentiment▼0.640.54▲Average Medical News Sentiment JNJ News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JNJ Articles This Week▼4529▲JNJ Articles Average Week Get Johnson & Johnson News Delivered to You Automatically Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Merck & Co., Inc. News Today AbbVie News Today Pfizer News Today Eli Lilly and Company News Today AstraZeneca News Today Novartis News Today Abbott Laboratories News Today Novo Nordisk A/S News Today Sanofi News Today Regeneron Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:JNJ) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsObama’s Forever Term [exposed]Porter & CompanyGold Set to EXPLODE!Gold Safe ExchangeThe 1,000X Crypto PlaybookTrue Market InsidersCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm PressWhy Is Gold On a MASSIVE rally? Huge AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Johnson & Johnson Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
